Amount Raised
$9.96 Million
Round Type
Post-IPO Equity
Fort WorthHealthcareHealth CareInvestors
Description
Actuate Therapeutics, Inc. successfully closed a public offering, raising approximately $9.96 million. The offering involved the sale of 30,985,900 shares of common stock and related warrants. The proceeds will support the company's ongoing development efforts.
Quick answer
Actuate Therapeutics raised $9.96 Million in a Post-IPO Equity round, dated October 28, 2026. Investors: Newbridge Securities Corporation. Actuate Therapeutics is based in Fort Worth, Texas, United States.
- How much did Actuate Therapeutics raise?
- Actuate Therapeutics raised $9.96 Million in a Post-IPO Equity round on October 28, 2026.
- Who invested in Actuate Therapeutics?
- Newbridge Securities Corporation is named as investors in this round.
- What does Actuate Therapeutics do?
- Actuate Therapeutics, Inc. (NASDAQ: ACTU) is a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers.
- Where is Actuate Therapeutics based and how big is it?
- Actuate Therapeutics is based in Fort Worth, Texas, United States. Fundz records about 14 employees.
- Who are the decision-makers at Actuate Therapeutics?
- Fundz holds 2 contacts at Actuate Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Health Care around the same time
Companies in the same sectors as Actuate Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Francis Medical raised an undisclosed amount on November 12, 2026.
- XpertDox LLC raised $20M (Series A) on November 11, 2026.
- Endovia Health Sciences, Inc. raised $135M (Post-IPO Equity) on October 27, 2026.
- Os Therapies raised $7.2M on October 15, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- Ospitek raised an undisclosed amount on October 13, 2026.
Who to call at Actuate Therapeutics, and when
A new round usually means Actuate Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Actuate Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Actuate Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Actuate Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Actuate Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Actuate Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.